MBII
Income statement / Annual
Last year (2021), Marrone Bio Innovations, Inc.'s total revenue was $44.31 M,
an increase of 44,210.00% from the previous year.
In 2021, Marrone Bio Innovations, Inc.'s net income was -$16.55 M.
See Marrone Bio Innovations, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
FY-2013
|
FY-2012
|
| Period Ended |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
12/31/2013 |
12/31/2012 |
| Operating Revenue |
$44.31 M
|
$100,000.00
|
$29.37 M
|
$21.22 M
|
$18.17 M
|
$14.04 M
|
$9.80 M
|
$9.14 M
|
$14.54 M
|
$7.14 M
|
| Cost of Revenue |
$17.06 M |
$40,000.00 |
$13.26 M |
$10.91 M |
$10.53 M |
$9.52 M |
$9.26 M |
$9.44 M |
$10.74 M |
$4.33 M |
| Gross Profit |
$27.25 M |
$60,000.00 |
$16.11 M |
$10.31 M |
$7.64 M |
$4.52 M |
$545,000.00 |
-$302,000.00 |
$3.81 M |
$2.81 M |
| Gross Profit Ratio |
0.61 |
0.6 |
0.55 |
0.49 |
0.42 |
0.32 |
0.06 |
-0.03 |
0.26 |
0.39 |
| Research and Development
Expenses |
$12.08 M
|
$30,000.00
|
$14.03 M
|
$10.66 M
|
$10.82 M
|
$9.67 M
|
$13.50 M
|
$19.28 M
|
$17.81 M
|
$12.74 M
|
| General & Administrative
Expenses |
$0.00
|
$75,000.00
|
$30.07 M
|
$19.16 M
|
$19.81 M
|
$18.51 M
|
$26.50 M
|
$28.95 M
|
$15.02 M
|
$0.00
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$30.57 M
|
$75,000.00
|
$30.07 M
|
$19.16 M
|
$19.81 M
|
$18.51 M
|
$26.50 M
|
$28.95 M
|
$15.02 M
|
$0.00
|
| Other Expenses |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$10.29 M |
| Operating Expenses |
$42.65 M |
$105,000.00 |
$44.10 M |
$29.82 M |
$30.63 M |
$28.18 M |
$40.00 M |
$48.23 M |
$32.83 M |
$23.04 M |
| Cost And Expenses |
$59.71 M |
$145,000.00 |
$57.36 M |
$40.72 M |
$41.16 M |
$37.70 M |
$49.26 M |
$57.67 M |
$43.57 M |
$27.37 M |
| Interest Income |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$1,000.00 |
$37,000.00 |
$51,000.00 |
$59,000.00 |
$49,000.00 |
$16,000.00 |
| Interest Expense |
$1.57 M |
$4,000.00 |
$1.47 M |
$2.51 M |
$7.73 M |
$7.30 M |
$4.36 M |
$2.91 M |
$6.00 M |
$2.47 M |
| Depreciation &
Amortization |
$4.57 M
|
$3.56 M
|
$3.15 M
|
$1.89 M
|
$2.04 M
|
$2.24 M
|
$3.51 M
|
$2.58 M
|
$976,000.00
|
$613,000.00
|
| EBITDA |
-$10.37 M
|
$3.51 M
|
-$32.53 M
|
-$15.82 M
|
-$21.15 M
|
-$21.53 M
|
-$35.86 M
|
-$46.17 M
|
-$21.52 M
|
-$35.72 M
|
| EBITDA Ratio |
-0.23 |
35.09 |
-1.11 |
-0.75 |
-1.16 |
-1.53 |
-3.66 |
-5.05 |
-1.48 |
-5 |
| Operating Income Ratio
|
-0.34
|
-171.95
|
-0.95
|
-0.92
|
-1.27
|
-1.68
|
-4.03
|
-5.31
|
-2
|
-3.34
|
| Total Other
Income/Expenses Net |
-$1.57 M
|
$17.14 M
|
-$9.19 M
|
-$709,000.00
|
-$7.93 M
|
-$7.41 M
|
-$4.27 M
|
-$3.13 M
|
$536,000.00
|
-$14.96 M
|
| Income Before Tax |
-$16.51 M |
-$53,000.00 |
-$37.18 M |
-$20.21 M |
-$30.93 M |
-$31.07 M |
-$43.73 M |
-$51.66 M |
-$28.49 M |
-$38.79 M |
| Income Before Tax Ratio
|
-0.37
|
-0.53
|
-1.27
|
-0.95
|
-1.7
|
-2.21
|
-4.46
|
-5.65
|
-1.96
|
-5.43
|
| Income Tax Expense |
$45,000.00 |
$17.15 M |
$15,000.00 |
$1.80 M |
-$201,000.00 |
-$109,000.00 |
$92,000.00 |
-$219,000.00 |
$6.53 M |
-$12.49 M |
| Net Income |
-$16.55 M |
-$53,000.00 |
-$37.18 M |
-$20.21 M |
-$30.93 M |
-$31.07 M |
-$43.73 M |
-$51.66 M |
-$28.49 M |
-$38.79 M |
| Net Income Ratio |
-0.37 |
-0.53 |
-1.27 |
-0.95 |
-1.7 |
-2.21 |
-4.46 |
-5.65 |
-1.96 |
-5.43 |
| EPS |
-0.0947 |
-0.0004 |
-0.32 |
-0.2 |
-1.06 |
-1.26 |
-1.79 |
-2.32 |
-3.26 |
-2.12 |
| EPS Diluted |
-0.0947 |
-0.0004 |
-0.32 |
-0.2 |
-1.06 |
-1.26 |
-1.79 |
-2.32 |
-3.2 |
-2.12 |
| Weighted Average Shares
Out |
$174.83 M
|
$148.89 M
|
$117.98 M
|
$101.25 M
|
$29.24 M
|
$24.62 M
|
$24.47 M
|
$22.31 M
|
$8.73 M
|
$18.27 M
|
| Weighted Average Shares
Out Diluted |
$174.83 M
|
$148.89 M
|
$117.98 M
|
$101.25 M
|
$29.24 M
|
$24.62 M
|
$24.47 M
|
$22.31 M
|
$8.91 M
|
$18.27 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
